We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWTG:NASDAQNewton Golf Company, Inc. Analysis

Data as of 2026-08-11 - not real-time

$1.21

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Newton Golf Company, Inc. is neutral at $1.21, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 25.9%. Momentum indicators put RSI at 60.2 (approaching overbought) with MACD reading bullish. Watch $0.9710 as support and $1.25 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 292.6% above today's level. Revenue is contracting at 18.1% on a -103.0% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 112.6%, a beta of 1.02 and a maximum drawdown of 62.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Updated Jul 9, 2026 0 CAMARILLO, Calif.-- BUSINESS WIRE --Jul 9, 2026-- Newton Golf Company, Inc. NASDAQ: NWTG , a...Updated Jun 4, 2026 0 CAMARILLO, Calif.-- BUSINESS WIRE --Jun 4, 2026-- Newton Golf Company, Inc. NASDAQ: NWTG , a...Morningstar1monNewton Golf Secures $5.0 Million Revolving Credit Facility and Completes Exchange of $2.3 Million of...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 1.33
  • MACD momentum is positive
  • 30-day price change of +25.9%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 1.33
  • Analyst targets imply +292.6% versus the current price
  • 30-day volatility of 112.6%

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -103.0%
  • Analyst targets imply +292.6% versus the current price
  • Negative return on equity of -348.7%

Key Metrics & Analysis

Financial Health

Revenue Growth-18.10%
Profit Margin-103.01%
P/E Ratio-3.7
ROE-348.69%
ROA-94.24%
P/B Ratio-3.7
Op. Cash Flow$-4697000
Free Cash Flow$-2433250

Technical Analysis

TrendNeutral
RSI60.2
Support$0.97
Resistance$1.25
MA 20$1.10
MA 50$1.01
MA 200$1.33
MACDBullish
VolumeStable
Fear & Greed Index94.14

Valuation

Target Price$4.75
Upside/Downside292.56%
GradeFair
TypeBlend

Risk Assessment

Beta1.02
Volatility112.57%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.